AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding AbCellera Biologics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of ABCL: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	143	1	154	+12
Shares	119.2M	500	121.0M	+1.85M (+1.6%)
Value	$681.1M	$2.85K	$547.4M	−$133.7M (−19.6%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held AbCellera Biologics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ABCL in Q1 2024
Institution	Shares	Value	% of portfolio
Man Group plc	771,934	$3.50M	0.01%
Mirae Asset Global Investments Co., Ltd.	100,145	$729.8K	0.00%
Tudor Investment Corp Et Al	90,734	$411.0K	0.01%
State Board of Administration of Florida Retirement System	52,800	$398.1K	0.00%
LPL Financial LLC	65,743	$297.8K	0.00%
Ratan Capital Management LP	47,265	$214.1K	0.11%
Pier 88 Investment Partners LLC	34,980	$158.5K	0.04%
Fox Run Management, L.L.C.	31,123	$141.0K	0.03%
Cetera Investment Advisers	22,877	$103.6K	0.00%
Parkwood LLC	21,533	$98.0K	0.01%
Aquatic Capital Management LLC	18,700	$84.7K	0.00%
PFG Investments, LLC	16,600	$75.2K	0.00%
Vontobel Holding Ltd.	15,311	$69.4K	0.00%
Scotia Capital Inc.	15,069	$68.3K	0.00%
Seelaus Asset Management LLC	15,000	$68.0K	0.07%
Occudo Quantitative Strategies LP	13,630	$61.7K	0.01%
Voloridge Investment Management, LLC	13,448	$60.9K	0.00%
Invesco Ltd.	11,428	$51.8K	0.00%
Allianz Asset Management GmbH	10,393	$47.1K	0.00%
Jackson Square Capital, LLC	10,230	$46.3K	0.01%
EntryPoint Capital, LLC	3,728	$16.9K	0.02%
Jones Financial Companies LLLP	3,281	$14.9K	0.00%
nVerses Capital, LLC	1,100	$4.98K	0.01%
Plante Moran Financial Advisors, LLC	434	$1.97K	0.00%
Rhumbline Advisers	135	$611	0.00%
Atticus Wealth Management, LLC	100	$453	0.00%
Continuum Advisory, LLC	93	$367	0.00%

Sold out (15)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ABCL in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	659,750	$3.77M
Algert Global LLC	102,870	$587.4K
HRT Financial LP	90,562	$517.0K
Alliancebernstein L.P.	39,472	$225.4K
MQS Management LLC	35,223	$201.1K
Cetera Advisors LLC	22,638	$129.3K
Cookson Peirce & Co Inc	20,000	$114.0K
Aigen Investment Management, LP	15,724	$89.8K
Vanguard Group Inc	13,112	$74.9K
C M Bidwell & Associates Ltd	758	$4.33K
Walleye Trading LLC	748	$4.27K
Householder Group Estate & Retirement Specialist, LLC	500	$2.00K
LM Advisors LLC	200	$1.14K
Financial Synergies Wealth Advisors, Inc.	89	$902
Northwestern Mutual Wealth Management Co	150	$857

Not filed for Q1 2024 yet (1)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Baystate Wealth Management LLC	500	$2.85K